This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Apple, where the perfect is the enemy of the good

Stocks in this article: AAPLAROAXPGESJCPMSFTPFEQCOMUSB

By Libardo Lambrano

On September 21, 2012, Apple (AAPL) reached $700 per share for the first time, only to go back down to $390 per share six months later. The company has had a fantastic run since 2010, but its current price of $628 is still under the $700 peak in 2012.

Apple invests huge amounts of money in research, design and development, but it seems that the company may be suffering from the paralysis of perfectionism syndrome. The endless pursuit of the perfect, the enemy of the good and product execution, famously killed off Duke Nukem, one of the best computer games of all time.

The original Duke Nukem game was so successful that the development team tasked to create a sequel utterly failed. George Broussard, one of the owners of 3D Realms, the creator of the game, forced his team to re-start from scratch every time a new gaming technology was available (which at the time seemed to be almost every day).

After Broussard and his partner Scott Miller had spent $20 million of their own money over a span of 12 years, they disbanded all development at 3D Realms in 2009. In the quest for the perfect sequel to an original game released in 1996, nothing was ever released.

This is one of the most interesting stories of success paralysis in recent history. A similar challenge seems to be plaguing Apple lately. It's not clear whether executives are perfecting the Apple TV or Apple smart-watch, but something is clearly in the works.

Is Apple waiting for the perfect moment that may never arrive? In contrast to 3D Realms, Apple is one of the largest companies in the world. Even so, the company (and its share price) risk stagnation if innovation and product launches stop. Just ask Bill Gates and the team at Microsoft (MSFT).

In November 2012, I reduced my position in Apple, due to rising business expenses and increasing competition. Yet even after that slight reduction, the stock still comprises close to 10% of my entire portfolio.

Will Apple really be able to launch a game-changing product again? iTunes radio was a complete fiasco. It never got better: it was difficult to use and glitchy, and was years behind of rdio, Spotify or even Pandora. I just cancelled my subscription and moved on to a different service.

I am curious to see what develops after their recent acquisition of Beats - especially since Apple is a company that hasn't done a lot of large acquisitions in the past. I'm still invested in Apple for the long run, but since questions remain I plan to keep a close eye on it.

As of June 19th, since inception (01/19/12), the model is up 18.6.% (annualized) through the end of May, versus 20.8% for the S&P 500 Index (SPX). The return of the S&P 500 in May 2014 was close to 2.1%, as compared with close to 2.0% for my Dividend Paying Large Caps portfolio. Year-to-date my portfolio is up 6.19% as compared with 4.07% of the S&P 500.

In May, Apple (AAPL), JC Penny (JCP), and American Express (AXP) all performed well. They were up 7.3%, 5.5%, and 4.7% respectively. The stock that hurt my portfolio in May was actually one of my recent acquisitions: Pfizer (PFE), which declined -5.3% after the failed $117 billion bid for AztraZeneca (AZN).

At 18.11 PE and 3.5% dividend, Pfizer is a position I'll plan to hold for the rest of the year. Pfizer is one of the large cap companies with more aggressive stock buyback programs, which shows management responsibility and commitment to investors.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs